Align Technology/$ALGN
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Align Technology
Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.
Ticker
$ALGN
Sector
Primary listing
Industry
Health Care Equipment & Supplies
Headquarters
Employees
21,200
ISIN
US0162551016
Website
Align Technology Metrics
BasicAdvanced
$13B
32.73
$5.50
1.68
-
Price and volume
Market cap
$13B
Beta
1.68
52-week high
$263.24
52-week low
$141.74
Average daily volume
829K
Financial strength
Current ratio
1.206
Quick ratio
0.972
Long term debt to equity
2.279
Total debt to equity
3.124
Profitability
EBITDA (TTM)
807.307
Gross margin (TTM)
70.02%
Net profit margin (TTM)
10.29%
Operating margin (TTM)
16.55%
Effective tax rate (TTM)
30.70%
Revenue per employee (TTM)
$190,000
Management effectiveness
Return on assets (TTM)
6.72%
Return on equity (TTM)
10.84%
Valuation
Price to earnings (TTM)
32.732
Price to revenue (TTM)
3.368
Price to book
3.49
Price to tangible book (TTM)
4.09
Price to free cash flow (TTM)
21.254
Free cash flow yield (TTM)
4.70%
Free cash flow per share (TTM)
846.93%
Growth
Revenue change (TTM)
1.64%
Earnings per share change (TTM)
-9.32%
3-year revenue growth (CAGR)
-0.42%
10-year revenue growth (CAGR)
17.72%
3-year earnings per share growth (CAGR)
-14.77%
10-year earnings per share growth (CAGR)
11.69%
What the Analysts think about Align Technology
Analyst ratings (Buy, Hold, Sell) for Align Technology stock.
Bulls say / Bears say
Align Technology's recent introduction of the Invisalign Palatal Expander, its first direct 3D-printed orthodontic appliance, demonstrates the company's commitment to innovation and may drive future revenue growth. (beyondspx.com)
The company's ongoing investments in the development of its iTero Lumina scanner and the expansion of its Align Digital Platform are expected to further solidify its position as a leading provider of integrated solutions for dental professionals. (beyondspx.com)
Align Technology's strong financial position, with a low debt-to-equity ratio of 0.02 as of 2024, indicates low leverage and effective utilization of shareholder equity, providing a solid foundation for future growth. (tipranks.com)
Analysts estimate Align Technology to report a decline in earnings for the quarter ended March 2025, which could negatively impact investor sentiment. (finviz.com)
Align Technology missed Wall Street estimates for third-quarter revenue on October 23, 2024, due to lower-than-expected demand for its clear teeth aligners among younger patients. (reuters.com)
The company is facing a decline in Invisalign average selling prices for comprehensive treatment options, resulting in a decline in revenues. (zacks.com)
Data summarised monthly by Lightyear AI. Last updated on 4 Jun 2025.
Align Technology Financial Performance
Revenues and expenses
Align Technology Earnings Performance
Company profitability
Align Technology News
AllArticlesVideos
Align Technology Launches Integrated Consumer and Professional Brand Campaign Focused on Invisalign® Treatment for Kids and Teens
Business Wire·3 days ago
Align Technology Awards Funding to Universities Worldwide for Advancing Orthodontic and Dental Research
Business Wire·3 weeks ago
Align Technology Launches Professional Marketing Initiative Featuring Doctors at the Forefront of Digital Orthodontics and Their Stories in Transforming More Than 20M Smiles With Invisalign® Aligners
Business Wire·4 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Align Technology stock?
Align Technology (ALGN) has a market cap of $13B as of June 20, 2025.
What is the P/E ratio for Align Technology stock?
The price to earnings (P/E) ratio for Align Technology (ALGN) stock is 32.73 as of June 20, 2025.
Does Align Technology stock pay dividends?
No, Align Technology (ALGN) stock does not pay dividends to its shareholders as of June 20, 2025.
When is the next Align Technology dividend payment date?
Align Technology (ALGN) stock does not pay dividends to its shareholders.
What is the beta indicator for Align Technology?
Align Technology (ALGN) has a beta rating of 1.68. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.